Biogen Analysis
Executive Summary
Biogen is a global biotechnology company headquartered in Cambridge, Massachusetts. Biogen is engaged in the research and development of biopharmaceuticals for human health care. Its main product is Avonex, a drug for the treatment of Multiple Sclerosis. Eighty-two percent of its revenues in 2000 came from the sale of this sole product. Biogen is also involved in the research of drugs for psoriasis, Crohn's disease, congestive heart failure, and cancer. Biogen believes that its success is based on its employees, and its corporate culture reflects this belief. Its culture is embedded in its corporate values. These values consist of hiring the highest quality employees, flexibility in work, leadership, and teamwork.
Biogen is in a strong position within the biotechnology industry. It is one of just seventeen profitable biotech companies and has the fourth largest market capitalization. Biogen has attained this prestige by utilizing partnerships from......
View the rest of this paper...
Approximate Word Count: 7581
Approximate Pages: 31 (250 words per double-spaced page)
Why should you join Frat Files?
- - It's safe, secure, and private.
- - Instant access to over 100,000 papers. New papers are added hourly.
- - Fast and reliable customer support.
Similar Essays
-
Biogen Analysis
Biogen Analysis. Executive Summary Biogen ... based. Strategic Analysis Biogen is
still continuing to expand into foreign markets. This provides ... -
Environmental Analysis
... Competitor Analysis The main competitors of Genentech in the biotechnology field
are – Amgen, Bristol-Myers Squibb, Biogen and GlaxoSmithkline. ... -
Venture Capital
... Biogen is a bio-technology firm with a patent on a drug called Avonex, which has
received FDA approval for use in treating multiple ... An internal analysis of the ...
Frat Files
Members
Information
